Inspire Medical Systems, Inc.
INSP · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $3,829 | $4,731 | $5,517 |
| - Cash | $113 | $107 | $54 | $150 |
| + Debt | $30 | $33 | $34 | $32 |
| Enterprise Value | – | $3,755 | $4,711 | $5,399 |
| Revenue | $225 | $217 | $201 | $240 |
| % Growth | 3.4% | 7.8% | -16% | – |
| Gross Profit | $193 | $182 | $171 | $204 |
| % Margin | 85.8% | 84% | 84.7% | 85% |
| EBITDA | $17 | $1 | $2 | $57 |
| % Margin | 7.7% | 0.5% | 0.8% | 23.7% |
| Net Income | $10 | -$4 | $3 | $35 |
| % Margin | 4.4% | -1.7% | 1.5% | 14.7% |
| EPS Diluted | 0.34 | -0.12 | 0.1 | 1.15 |
| % Growth | 383.3% | -220% | -91.3% | – |
| Operating Cash Flow | $69 | $3 | -$7 | $69 |
| Capital Expenditures | -$10 | -$9 | -$8 | -$7 |
| Free Cash Flow | $58 | -$6 | -$15 | $62 |